3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pheochromocytoma
2
Paraganglioma
2
Neuroendocrine Tumors
2
Meningioma
2
von Hippel-Lindau Disease
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Neuroendocrine Prostate Cancer
1
Kidney Neoplasms
1
Hypertension
1
Head and Neck Neoplasms
1
Ganglioneuroma
1
Ganglioneuroblastoma
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Temozolomide
10
Radiotherapy
5
Radiation
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
Specimen Handling
2
Photons
2
Nivolumab
2
veliparib
1
sargramostim
1
peposertib
1
montanide ISA 51
1
liposomal doxorubicin
1
cemiplimab
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Utrogestan
1
Surgical Procedures, Operative
1
Sonication
1
Progestins
1
Progesterone
1
Perfusion Magnetic Resonance Imaging
1
Mycophenolic Acid
1
Lomustine
1
Irinotecan
1
Drug Therapy
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gliosarcoma
×
gallium Ga 68 dotatate
×
90 days
×
Clear all
No trials found.